Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Regarding Preparations for Discussions with the U.S. FDA on DFP-10917 Monotherapy and Combination Therapy with Venetoclax
Notice Regarding Partial Corrections and Inquiries Regarding the Announcement Regarding the DMC on the P1/2 of DFP-10917+VEN
Announcement Regarding the Data Monitoring Committee Decision on the Phase 1/2 Study of DFP-10917 combination with Venetoclax in Relapsed or Refractor
Follow up Interim analysis for Phase 3 Study of DFP-10917
Update DFP-10917 combo-therapy with VEN
Update for DFP-10917 related clinical studies
Progress status of DFP-10917 involved clinical studies
First Patient Enrolled in Phase 2/3 Randomized Study of DFP-17729 for Pancreatic Cancer in Japan
Progress status for Phase 1/2 study of DFP-10917 with Venetoclax (VEN) in the 2nd line AML
Announcement of novel patent filing for the DFP-10917 drug product
Announcement for a phase 2/3 study of DFP-17729 to be started